Suppr超能文献

人布鲁氏菌疫苗株104M的全面蛋白质基因组学研究。

A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M.

作者信息

Zai Xiaodong, Yang Qiaoling, Liu Kun, Li Ruihua, Qian Mengying, Zhao Taoran, Li Yaohui, Yin Ying, Dong Dayong, Fu Ling, Li Shanhu, Xu Junjie, Chen Wei

机构信息

Laboratory of Vaccine and Antibody Engineering, Beijing Institute of Biotechnology, Beijing, China.

出版信息

BMC Genomics. 2017 May 23;18(1):402. doi: 10.1186/s12864-017-3800-9.

Abstract

BACKGROUND

Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans. Although the B. abortus 104 M genome has been fully sequenced, the current genome annotations are not yet complete. In addition, the main mechanisms underpinning its residual toxicity and vaccine-induced immune protection have yet to be elucidated. Mapping the proteome of B. abortus 104 M will help to improve genome annotation quality, thereby facilitating a greater understanding of its biology.

RESULTS

In this study, we utilized a proteogenomic approach that combined subcellular fractionation and peptide fractionation to perform a whole-proteome analysis and genome reannotation of B. abortus 104 M using high-resolution mass spectrometry. In total, 1,729 proteins (56.3% of 3,072) including 218 hypothetical proteins were identified using the culture conditions that were employed this study. The annotations of the B. abortus 104 M genome were also refined following identification and validation by reverse transcription-PCR. In addition, 14 pivotal virulence factors and 17 known protective antigens known to be involved in residual toxicity and immune protection were confirmed at the protein level following induction by the 104 M vaccine. Moreover, a further insight into the cell biology of multichromosomal bacteria was obtained following the elucidation of differences in protein expression levels between the small and large chromosomes.

CONCLUSIONS

The work presented in this report used a proteogenomic approach to perform whole-proteome analysis and genome reannotation in B. abortus 104 M; this work helped to improve genome annotation quality. Our analysis of virulence factors, protective antigens and other protein effectors provided the basis for further research to elucidate the mechanisms of residual toxicity and immune protection induced by the 104 M vaccine. Finally, the potential link between replication dynamics, gene function, and protein expression levels in this multichromosomal bacterium was detailed.

摘要

背景

布鲁氏菌属是革兰氏阴性兼性胞内病原体,可在人类和动物中引起布鲁氏菌病。流产布鲁氏菌疫苗株104M是中国唯一可用于预防人类布鲁氏菌病的疫苗。尽管流产布鲁氏菌104M的基因组已被完全测序,但目前的基因组注释尚未完成。此外,其残余毒性和疫苗诱导的免疫保护的主要机制尚未阐明。绘制流产布鲁氏菌104M的蛋白质组图谱将有助于提高基因组注释质量,从而促进对其生物学特性的更深入了解。

结果

在本研究中,我们采用了一种蛋白质基因组学方法,该方法结合亚细胞分级分离和肽段分级分离,使用高分辨率质谱对流产布鲁氏菌104M进行全蛋白质组分析和基因组重新注释。在本研究采用的培养条件下,共鉴定出1729种蛋白质(占3072种的56.3%),其中包括218种假定蛋白质。通过逆转录PCR进行鉴定和验证后,流产布鲁氏菌104M基因组的注释也得到了完善。此外,在104M疫苗诱导后,在蛋白质水平上确认了14种关键毒力因子和17种已知参与残余毒性和免疫保护的保护性抗原。此外,在阐明小染色体和大染色体之间蛋白质表达水平的差异后,对多染色体细菌的细胞生物学有了进一步的认识。

结论

本报告中的工作采用蛋白质基因组学方法对流产布鲁氏菌104M进行全蛋白质组分析和基因组重新注释;这项工作有助于提高基因组注释质量。我们对毒力因子、保护性抗原和其他蛋白质效应物的分析为进一步研究阐明104M疫苗诱导的残余毒性和免疫保护机制提供了基础。最后,详细阐述了这种多染色体细菌中复制动力学、基因功能和蛋白质表达水平之间的潜在联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b9c/5442703/15c77bfeee0b/12864_2017_3800_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验